BRIEF published on 04/30/2025 at 18:05, 10 months 26 days ago Neovacs fundraising: a 0.25 million euro operation Biotechnology Fundraising Shareholder Dilution Néovacs OCEANE-BSA
BRIEF published on 04/30/2025 at 18:05, 10 months 26 days ago Levée de fonds de Néovacs : une opération de 0,25 million d'euros Biotechnologie Levée De Fonds Néovacs OCEANE-BSA Dilution Actionnaire
PRESS RELEASE published on 04/30/2025 at 18:00, 10 months 26 days ago Levée de fonds de 0,25 MEUR Néovacs annonce levée fonds 0,25M€ par émission d'OCEANE-BSA pour financer recherche allergies et investir en Biotech/Medtech. Détails communiqués Biotech MedTech Levée De Fonds Néovacs OCEANE-BSA
BRIEF published on 04/17/2025 at 18:35, 11 months 9 days ago Fundraising of 0.25 Million Euros by Neovacs Fundraising Shareholder Dilution Biotech Néovacs OCEANE-BSA
BRIEF published on 04/17/2025 at 18:35, 11 months 9 days ago Levée de Fonds de 0,25 Million d'Euros par Néovacs Biotech Levée De Fonds Néovacs OCEANE-BSA Dilution Actionnaire
PRESS RELEASE published on 04/17/2025 at 18:30, 11 months 9 days ago Levée de fonds de 0,25 M EUR Néovacs annonce une levée de fonds de 0,25 M€ par l'émission d'OCEANE-BSA destinée au développement de la recherche Kinoïde® sur les allergies et à l'investissement dans des projets prometteurs en BioTech et MedTech Biotech MedTech Levée De Fonds Néovacs OCEANE-BSA
BRIEF published on 04/16/2025 at 08:05, 11 months 11 days ago Neovacs Addresses Rumors About PXT3003 Biopharmaceuticals Market Authorization PXT3003 Tasly Charcot-Marie-Tooth
BRIEF published on 04/16/2025 at 08:05, 11 months 11 days ago Néovacs s'exprime sur les rumeurs concernant le PXT3003 Biopharmaceutique PXT3003 Tasly Charcot-Marie-Tooth Autorisation Marché
PRESS RELEASE published on 04/16/2025 at 08:00, 11 months 11 days ago Néovacs fait le point sur des rumeurs Néovacs fait le point sur les rumeurs concernant l'autorisation de mise sur le marché de PXT3003 en Chine et l'impact potentiel sur ses actifs. Aucune confirmation disponible pour le moment Autorisation De Mise Sur Le Marché Néovacs PXT3003 Impact Potentiel Procédure De Liquidation
BRIEF published on 04/02/2025 at 20:05, 11 months 24 days ago Adjustment of the nominal value of Neovacs shares Shareholders Capital Reduction Dilutive Financing Nominal Value Néovacs
Published on 03/27/2026 at 15:35, 37 minutes ago SouthGobi Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
Published on 03/27/2026 at 12:30, 3 hours 42 minutes ago Pasinex Closes First Tranche of Over-Subscribed Non-Brokered Private Placement
Published on 03/27/2026 at 12:00, 4 hours 12 minutes ago Temas Appoints Scientific Advisory Board to Accelerate RCL Commercialisation and Global Development
Published on 03/27/2026 at 11:00, 5 hours 12 minutes ago RE Royalties Announces Strategic Review to Evaluate Path for Long-Term Value Creation
Published on 03/27/2026 at 15:58, 14 minutes ago coinIX remains resilient in volatile market environment with balanced annual result | CEO Moritz Schildt sees entry-level prices in the crypto market
Published on 03/27/2026 at 15:50, 22 minutes ago EQS-Adhoc: Klöckner & Co SE: Worthington Steel announces intention to enter into a domination and profit and loss transfer agreement with Klöckner & Co SE
Published on 03/27/2026 at 15:05, 1 hour 7 minutes ago Huawei's 6th Global Installer Summit: Gathering the Best Installers to Embrace Renewable Energy Opportunities in the AI Era
Published on 03/27/2026 at 14:31, 1 hour 41 minutes ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 03/27/2026 at 07:00, 9 hours 12 minutes ago WEB SA - CONVOCATION ASSEMBLEE GENERALE ORDINAIRE EXERCICE 2025 - 28/04/2026
Published on 03/26/2026 at 18:17, 21 hours 55 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 21 hours 55 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 22 hours 12 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
